Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RTL
3026
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $4.2M | ﹤0.01% |
522,520
+238,743
| +84% | +$2.02M |
|
|
IS
3027
DELISTED
ironSource Ltd.
IS
| $4.2M | ﹤0.01% |
386,403
-283,193
| -42% | -$2.81M |
|
|
JAMF
3028
DELISTED
Jamf
JAMF
| $4.2M | ﹤0.01% |
108,938
+85,180
| +359% | +$2.92M |
|
3029
CALL
International Paper
IP
$20.8B
| $4.19M | ﹤0.01% |
79,200
| – | – |
|
|
3030
PUT
International Paper
IP
$20.8B
| $4.19M | ﹤0.01% |
79,200
| – | – |
|
|
MSP
3031
DELISTED
Datto Holding Corp.
MSP
| $4.19M | ﹤0.01% |
175,399
+149,972
| +590% | +$3.88M |
|
|
NUVA
3032
CALL
DELISTED
NuVasive, Inc.
NUVA
| $4.19M | ﹤0.01% |
+70,000
| New | +$4.32M |
|
|
HSII
3033
DELISTED
Heidrick & Struggles
HSII
| $4.19M | ﹤0.01% |
93,853
+79,692
| +563% | +$3.36M |
|
3034
4D Molecular Therapeutics
FDMT
$810M
| $4.19M | ﹤0.01% |
155,258
-196,793
| -56% | -$5.61M |
|
|
SV
3035
DELISTED
Spring Valley Acquisition Corp. Class A Ordinary Share
SV
| $4.19M | ﹤0.01% |
414,559
+5,450
| +1% | +$53.3K |
|
3036
CALL
Qorvo
QRVO
$8.36B
| $4.18M | ﹤0.01% |
+25,000
| New | +$4.65M |
|
3037
CALL
Vipshop
VIPS
$6.42B
| $4.18M | ﹤0.01% |
375,000
| – | – |
|
|
JOFFU
3038
DELISTED
JOFF Fintech Acquisition Corp. Unit
JOFFU
| $4.18M | ﹤0.01% |
421,615
-357,115
| -46% | -$3.55M |
|
3039
RxSight
RXST
$293M
| $4.17M | ﹤0.01% |
+329,548
| New | +$4.54M |
|
|
ZUO
3040
DELISTED
Zuora, Inc.
ZUO
| $4.17M | ﹤0.01% |
251,837
-236,762
| -48% | -$3.99M |
|
|
NEUE
3041
DELISTED
NeueHealth
NEUE
| $4.17M | ﹤0.01% |
6,386
-9,687
| -60% | -$8.52M |
|
3042
Plexus
PLXS
$6.42B
| $4.17M | ﹤0.01% |
46,587
-42,248
| -48% | -$3.76M |
|
|
LITT
3043
DELISTED
Logistics Innovation Technologies Corp. Class A Common Stock
LITT
| $4.17M | ﹤0.01% |
+425,000
| New | +$4.13M |
|
3044
Trex
TREX
$4.66B
| $4.16M | ﹤0.01% |
40,786
+1,125
| +3% | +$118K |
|
|
OPLN
3045
Openlane
OPLN
$4.28B
| $4.16M | ﹤0.01% |
253,585
+26,470
| +12% | +$447K |
|
|
RFP
3046
DELISTED
Resolute Forest Products Inc.
RFP
| $4.16M | ﹤0.01% |
349,255
-139,915
| -29% | -$1.64M |
|
3047
Horace Mann Educators
HMN
$2.08B
| $4.15M | ﹤0.01% |
104,349
-181,894
| -64% | -$7.21M |
|
3048
PUT
Novavax
NVAX
$1.53B
| $4.15M | ﹤0.01% |
20,000
+11,500
| +135% | +$2.53M |
|
|
WSR
3049
DELISTED
Whitestone REIT
WSR
| $4.14M | ﹤0.01% |
423,775
+176,522
| +71% | +$1.62M |
|
|
CDR
3050
DELISTED
Cedar Realty Trust, Inc
CDR
| $4.14M | ﹤0.01% |
191,104
-46,788
| -20% | -$846K |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.